The Marine-Derived Sipholenol A-4-O-3′,4′-Dichlorobenzoate Inhibits Breast Cancer Growth and Motility in Vitro and in Vivo through the Suppression of Brk and FAK Signaling

por Akl, Mohamed R., Foudah, Ahmed I., Ebrahim, Hassan Y., Meyer, Sharon A., Sayed, Khalid A. El
Publicado 2014

The oleocanthal-based homovanillyl sinapate as a novel c-Met inhibitor

por Mohyeldin, Mohamed M., Akl, Mohamed R., Ebrahim, Hassan Y., Dragoi, Ana Maria, Dykes, Samantha, Cardelli, James A., El Sayed, Khalid A.
Publicado 2016

Olive Phenolics as c-Met Inhibitors: (-)-Oleocanthal Attenuates Cell Proliferation, Invasiveness, and Tumor Growth in Breast Cancer Models

por Akl, Mohamed R., Ayoub, Nehad M., Mohyeldin, Mohamed M., Busnena, Belnaser A., Foudah, Ahmed I., Liu, Yong-Yu, Sayed, Khalid A. EI
Publicado 2014

Araguspongine C Induces Autophagic Death in Breast Cancer Cells through Suppression of c-Met and HER2 Receptor Tyrosine Kinase Signaling

por Akl, Mohamed R., Ayoub, Nehad M., Ebrahim, Hassan Y., Mohyeldin, Mohamed M., Orabi, Khaled Y., Foudah, Ahmed I., El Sayed, Khalid A.
Publicado 2015

Molecular and clinical profiles of syndecan-1 in solid and hematological cancer for prognosis and precision medicine

por Akl, Mohamed R., Nagpal, Poonam, Ayoub, Nehad M., Prabhu, Sathyen A., Gliksman, Matthew, Tai, Betty, Hatipoglu, Ahmet, Goy, Andre, Suh, K. Stephen
Publicado 2015

Molecular and clinical significance of fibroblast growth factor 2 (FGF2 /bFGF) in malignancies of solid and hematological cancers for personalized therapies

por Akl, Mohamed R., Nagpal, Poonam, Ayoub, Nehad M., Tai, Betty, Prabhu, Sathyen A., Capac, Catherine M., Gliksman, Matthew, Goy, Andre, Suh, K. Stephen
Publicado 2016

Pediatric Hodgkin lymphoma– biomarkers, drugs, and clinical trials for translational science and medicine

por Nagpal, Poonam, Akl, Mohamed R., Ayoub, Nehad M., Tomiyama, Tatsunari, Cousins, Tasheka, Tai, Betty, Carroll, Nicole, Nyrenda, Themba, Bhattacharyya, Pritish, Harris, Michael B., Goy, Andre, Pecora, Andrew, Suh, K. Stephen
Publicado 2016

(−)-Oleocanthal Combined with Lapatinib Treatment Synergized against HER-2 Positive Breast Cancer In Vitro and In Vivo

por Siddique, Abu Bakar, Ebrahim, Hassan Y., Akl, Mohamed R., Ayoub, Nehad M., Goda, Amira A., Mohyeldin, Mohamed M., Nagumalli, Suresh K., Hananeh, Wael M., Liu, Yong-Yu, Meyer, Sharon A., El Sayed, Khalid A.
Publicado 2019